Upcoming Aditxt Weekly Update to Feature Dr. Shahrokh Shabahang, Chief Innovation Officer (CIO) of Aditxt™, and Dr. Friedrich Kapp, Co-CEO of Adimune™, to Discuss Progress of Lead Therapeutic Candidate ADI-100™
1. Aditxt to discuss developments on lead candidate ADI-100 in upcoming Weekly Update. 2. CIO and Adimune's Co-CEO to detail advancements impacting ADTX’s portfolio.